BackCytoMed Therapeutics Overview

CytoMed Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for GDTC.

Quarterly EBIT

-$1.83M
↓ 71.06% YoY

As of Dec 31, 2025

Annual EBIT (TTM)

-$4.61M
↓ 1.94% YoY

Trailing 12 months ending Dec 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin